Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 83, Issue 1 , Pages 15-22 , July 2010

CysLT1-R expression following allergen provocation in asthma and allergic rhinitis

Received 22 July 2009 ,Revised 25 January 2010 ,Accepted 22 February 2010.

References 

  1. Lundbäck B. Epidemiology of rhinitis and asthma. Clin. Exp. Allergy. 1998;28:3S–10S
  2. Gergen PJ, Weiss KB. The increasing problem of asthma in the United States. Am. Rev. Respir. Dis. 1992;146:823–824
  3. Foresi A, Leone C, Pelucchi A, et al. Eosinophils, mast cells, and basophils in induced sputum from patients with seasonal allergic rhinitis and perennial asthma: relationship to methacholine responsiveness. J. Allergy Clin. Immunol. 1997;100:58–64
  4. Alvarez MJ, Olaguibel JM, Garcia BE, Rodriguez A, Tabar AI, Urbiola E. Airway inflammation in asthma and perennial allergic rhinitis. Relationship with nonspecific bronchial responsiveness and maximal airway narrowing. Allergy. 2000;55:355–362
  5. Chakir J, Laviolette M, Boutet M, Laliberté R, Dubé J, Boulet LP. Lower airways remodeling in nonasthmatic subjects with allergic rhinitis. Lab. Invest. 1996;75:735–744
  6. Boulet LP, Morin D, Milot J, Turcotte H. Bronchial responsiveness increases after seasonal antigen exposure in non-asthmatic subjects with pollen-induced rhinitis. Ann. Allergy. 1989;63:114–119
  7. Di Lorenzo G, Mansueto P, Melluso M, et al. Non-specific airway hyperresponsiveness in mono-sensitive Sicilian patients with allergic rhinitis. Its relationship to total serum IgE levels and blood eosinophils during and out of the pollen season. Clin. Exp. Allergy. 1997;27:1052–1059
  8. Chakir J, Laviolette M, Turcotte H, Boutet M, Boulet LP. Cytokine expression in the lower airways of nonasthmatic subjects with allergic rhinitis: influence of natural allergen exposure. J. Allergy Clin. Immunol. 2000;106:904–910
  9. Braunstahl GJ, Overbeek SE, Kleinjan A, Prins JB, Hoogsteden HC, Fokkens WJ. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J. Allergy Clin. Immunol. 2001;107:469–476
  10. Bisgaard H. Role of leukotrienes in asthma pathophysiology. Pediatr. Pulmonol. 2000;30:166–176
  11. Philip G, Malmstrom K, Hampel FC, et al. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring. Clin. Exp. Allergy. 2002;32:1020–1028
  12. Price DB, Swern A, Tozzi CA, Philip G, Polos P. Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial. Allergy. 2006;61:737–742
  13. J.C. Virchow, C. Bachert, Efficacy and safety of montelukast in adults with asthma and allergic rhinitis. Respir. Med. 2006.
  14. Wilson AM, Orr LC, Sims EJ, Lipworth BJ. Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis. Clin. Exp. Allergy. 2001;31:61–68
  15. Diamant Z, Grootendorst DC, Veselic-Charvat M, et al. The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma. Clin. Exp. Allergy. 1999;29:42–51
  16. Parameswaran K, Liang H, Fanat A, Watson R, Snider DP, O'Byrne PM. Role for cysteinyl leukotrienes in allergen-induced change in circulating dendritic cell number in asthma. J. Allergy Clin. Immunol. 2004;114:73–79
  17. Palmqvist M, Bruce C, Sjostrand M, Arvidsson P, Lotvall J. Differential effects of fluticasone and montelukast on allergen-induced asthma. Allergy. 2005;60:65–70
  18. Parameswaran K, Watson R, Gauvreau GM, Sehmi R, O'Byrne PM. The effect of pranlukast on allergen-induced bone marrow eosinophilopoiesis in subjects with asthma. Am. J. Respir. Crit. Care Med. 2004;169:915–920
  19. Davis BE, Illamperuma C, Gauvreau GM, et al. Single-dose desloratadine and montelukast and allergen-induced late airway responses. Eur. Respir. J. 2009;33:1302–1308
  20. Kelly MM, Chakir J, Vethanayagam D, et al. Montelukast treatment attenuates the increase in myofibroblasts following low-dose allergen challenge. Chest. 2006;130:741–753
  21. Spanevello A, Confalonieri M, Sulotto F, et al. Induced sputum cellularity. Reference values and distribution in normal volunteers. Am. J. Respir. Crit. Care Med. 2000;162:1172–1174
  22. in't Veen JCCM, de Gouw HWFM, Smits HH, et al. Repeatability of cellular and soluble markers of inflammation in induced sputum from patients with asthma. Eur. Respir. J. 1996;9:2441–2447
  23. Pizzichini E, Pizzichini MMM, Efthimiadis A, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am. J. Respir. Crit. Care Med. 1996;154:308–317
  24. Lemiere C, Pelissier S, Tremblay C, et al. Leukotrienes and isocyanate-induced asthma: a pilot study. Clin. Exp. Allergy. 2004;34:1684–1689
  25. American Thoracic Society . Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am. Rev. Respir. Dis. 1987;136:225–244
  26. ATS Statement . Standardization of spirometry—1987 update. Am. Rev. Respir. Dis. 1987;136:1285–1298
  27. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am. Rev. Respir. Dis. 1983;127:725–734
  28. E.F. Juniper, D.W. Cockcroft, R. Kolendowicz, Histamine and Methacholine Inhalation Test: A Laboratory Tidal Breathing Protocol. 1994, pp. 1–49.
  29. Cockcroft DW, Murdock KY, Kirby J, Hargreave F. Prediction of airway responsiveness to allergen from skin sensitivity to allergen and airway responsiveness to histamine. Am. Rev. Respir. Dis. 1987;135:264–267
  30. Boulay ME, Boulet LP. Lower airway inflammatory responses to repeated very-low-dose allergen challenge in allergic rhinitis and asthma. Clin. Exp. Allergy. 2002;32:1441–1447
  31. Pin I, Freitag AP, O'Byrne PM, et al. Changes in the cellular profile of induced sputum after allergen-induced asthmatic responses. Am. Rev. Respir. Dis. 1992;145:1265–1269
  32. Beeh KM, Beier J, Kornmann O, Meier C, Taeumer T, Buhl R. A single nasal allergen challenge increases induced sputum inflammatory markers in non-asthmatic subjects with seasonal allergic rhinitis: correlation with plasma interleukin-5. Clin. Exp. Allergy. 2003;33:475–482
  33. Wilson AM, Duong M, Crawford L, Denburg J. An evaluation of peripheral blood eosinophil/basophil progenitors following nasal allergen challenge in patients with allergic rhinitis. Clin. Exp. Allergy. 2005;35:39–44
  34. Henderson WR, Chiang GK, Tien YT, Chi EY. Reversal of allergen-induced airway remodeling by CysLT1 receptor blockade. Am. J. Respir. Crit. Care Med. 2006;173:718–728
  35. Fireman P. Rhinitis and asthma connection: management of coexisting upper airway allergic diseases and asthma. Allergy Asthma Proc. 2000;21:45–54
  36. Togias A. Mechanisms of nose–lung interaction. Allergy. 1999;54(Suppl. 57):94–105
  37. Li J, Saito H, Crawford L, Inman MD, Cyr MM, Denburg JA. Haemopoietic mechanisms in murine allergic upper and lower airway inflammation. Immunology. 2005;114:386–396
  38. Figueroa DJ, Breyer RM, Defoe SK, et al. Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes. Am. J. Respir. Crit. Care Med. 2001;163:226–233
  39. de Monchy JGR, Kauffman HF, Venge P. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am. Rev. Respir. Dis. 1985;131:373–376
  40. Frew AJ, Kay AB. Eosinophils and T-lymphocytes in late-phase allergic reactions. J. Allergy Clin. Immunol. 1990;85:533–539

PII: S0952-3278(10)00077-3

doi: 10.1016/j.plefa.2010.02.033

Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 83, Issue 1 , Pages 15-22 , July 2010

Article Tools

* Image Usage & Resolution